Filter
13
Featured
Recommendations
4
New Publications
5
Language
Document type
No document type
10
Manuals
2
Guidelines
1
Authors & Publishers
Publication Years
Category
Virology
2
Pediatrics
2
Paediatrics
1
Hepatitis
1
Bacteriology
1
Medical Devices & Equipment
1
Parasitology
1
HIV & STI
1
Malaria
1
Pharmacy & Technologies
1
Toolboxes
Clinical Aspects, Treatment & Prevention
2
Children
1
Detection & Diagnosis
1
Advocacy & Communication
1
Drug resistance
1
Access to treatment and laboratory
1
Antiretroviral Treatment ART
1
Treatment & Prevention
1
HIV testing & services
1
HIV support organizations
1
Essential Medicines
1
Technology landscape
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United
...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three
...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
HIV i-Base
July 2018
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Lessons from the STEP-TB Project.
Accessed November 2017.
WHO Annual Meeting with Pharmaceutical Companies and Stakeholders
08 March 2016, Geneva
2015-06-03 - Board presentation - v32.pptx
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those
...
Progress in diagnosis: Akey in overcoming the MDR-TB crisis.
The expanse-TV project progress and impact brief.
